封面
市场调查报告书
商品编码
1981042

全球青光眼手术器械市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Glaucoma Surgery Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计青光眼手术器械的市场规模将从 2025 年的 25.8 亿美元增长到 2034 年的 196 亿美元,2026 年至 2034 年的复合年增长率为 25.27%。

由于青光眼发生率不断上升,全球青光眼手术器械市场正经历显着增长。青光眼是全球不可逆性失明的主要原因之一。青光眼手术器械用于降低眼内压,防止视神经进一步受损。早期诊断和手术介入对于控制病情进展至关重要。

技术进步正在改变青光眼的治疗选择,尤其是微创青光眼手术(MIGS)设备。这些创新设备使外科医生能够进行更安全、创伤更小的手术,并缩短患者的康復时间。眼科诊所和医院对先进眼科技术的日益普及正在推动市场成长。

随着全球人口老化和青光眼高发生风险持续存在,青光眼手术设备市场前景依然强劲。筛检计画的改进和眼健康意识的提高将进一步推动手术治疗的需求。眼科设备的持续创新将有助于改善治疗效果并扩大市场机会。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球青光眼手术器械市场:依手术类型划分

  • 市场分析、洞察与预测
  • 传统青光眼手术
  • 微创青光眼手术

第五章 全球青光眼手术器械市场:依产品分类

  • 市场分析、洞察与预测
  • 植入和支架
  • 青光眼引流装置
  • 青光眼雷射设备

第六章 全球青光眼手术器械市场:依最终使用者划分

  • 市场分析、洞察与预测
  • 眼科医院和眼科诊所
  • 门诊手术中心
  • 门诊手术中心

第七章 全球青光眼手术器材市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Abbvie Inc.(Allergan)
    • Alcon Inc
    • Glaukos Corporation
    • Johnson & Johnson(Abbott Medical Optics)
    • IStar Medical SA
    • Lumibird Medical(Ellex Medical Lasers Ltd)
    • Lumenis Ltd
    • New World Medical Inc
    • Santen Pharmaceutical Co. Ltd
    • Topcon Corporation
简介目录
Product Code: VMR112115635

The Glaucoma Surgery Devices Market size is expected to reach USD 19.60 Billion in 2034 from USD 2.58 Billion (2025) growing at a CAGR of 25.27% during 2026-2034.

The global glaucoma surgery devices market is witnessing significant growth due to the increasing prevalence of glaucoma, a major cause of irreversible blindness worldwide. Glaucoma surgery devices are used to reduce intraocular pressure and prevent further damage to the optic nerve. Early diagnosis and surgical intervention are essential for managing the progression of the disease.

Technological advancements are transforming glaucoma treatment options, particularly through minimally invasive glaucoma surgery (MIGS) devices. These innovative devices allow surgeons to perform safer and less invasive procedures with faster recovery times for patients. The increasing adoption of advanced ophthalmic technologies in eye care clinics and hospitals is supporting market growth.

Future prospects for the glaucoma surgery devices market remain strong as aging populations continue to increase the risk of glaucoma worldwide. Improved screening programs and growing awareness about eye health will further drive demand for surgical treatments. Continuous innovation in ophthalmic devices will help improve treatment outcomes and expand market opportunities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Surgery Type

  • Conventional Glaucoma Surgeries
  • Minimally Invasive Glaucoma Surgeries

By Product

  • Implants & Stents
  • Glaucoma Drainage Devices
  • Glaucoma Laser Devices

By End User

  • Eye Hospital & Ophthalmology Clinic
  • Ambulatory Surgical Centers (ASCS)
  • Outpatient Surgical Centers

COMPANIES PROFILED

  • Abbvie Inc Allergan, Alcon Inc, Glaukos Corporation, Johnson Johnson Abbott Medical Optics, iStar Medical SA, Lumibird Medical Ellex Medical Lasers Ltd, Lumenis Ltd, New World Medical Inc, Santen Pharmaceutical Co Ltd, Topcon Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY SURGERY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Surgery Type
  • 4.2. Conventional Glaucoma Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Minimally Invasive Glaucoma Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Implants & Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Glaucoma Drainage Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Glaucoma Laser Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Eye Hospital & Ophthalmology Clinic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers (ASCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Outpatient Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Surgery Type
    • 7.2.2 By Product
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Surgery Type
    • 7.3.2 By Product
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Surgery Type
    • 7.4.2 By Product
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Surgery Type
    • 7.5.2 By Product
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Surgery Type
    • 7.6.2 By Product
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL GLAUCOMA SURGERY DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbvie Inc. (Allergan)
    • 9.2.2 Alcon Inc
    • 9.2.3 Glaukos Corporation
    • 9.2.4 Johnson & Johnson (Abbott Medical Optics)
    • 9.2.5 IStar Medical SA
    • 9.2.6 Lumibird Medical (Ellex Medical Lasers Ltd)
    • 9.2.7 Lumenis Ltd
    • 9.2.8 New World Medical Inc
    • 9.2.9 Santen Pharmaceutical Co. Ltd
    • 9.2.10 Topcon Corporation